Scholars@Duke

Aspirin: it's hard to beat.

Publication ,  Journal Article
Anderson, DC; Goldstein, LB
Published in: Neurology
April 13, 2004
Published version (DOI) Link to item

Duke Scholars

Larry Bruce Goldstein
Author Larry Bruce Goldstein Neurology, Stroke and Vascular Neurology

Published In

Neurology

DOI

10.1212/wnl.62.7.1036

EISSN

1526-632X

Publication Date

April 13, 2004

Volume

62

Issue

7

Start / End Page

1036 / 1037

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Salicylates
  • Randomized Controlled Trials as Topic
  • Platelet Aggregation Inhibitors
  • Pilot Projects
  • Neurology & Neurosurgery
  • Humans
  • Cerebral Infarction
  • Aspirin
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Anderson, D. C., & Goldstein, L. B. (2004). Aspirin: it's hard to beat. Neurology, 62(7), 1036–1037. https://doi.org/10.1212/wnl.62.7.1036
Anderson, David C., and Larry B. Goldstein. “Aspirin: it's hard to beat.” Neurology 62, no. 7 (April 13, 2004): 1036–37. https://doi.org/10.1212/wnl.62.7.1036.
Anderson DC, Goldstein LB. Aspirin: it's hard to beat. Neurology. 2004 Apr 13;62(7):1036–7.
Anderson, David C., and Larry B. Goldstein. “Aspirin: it's hard to beat.” Neurology, vol. 62, no. 7, Apr. 2004, pp. 1036–37. Pubmed, doi:10.1212/wnl.62.7.1036.
Anderson DC, Goldstein LB. Aspirin: it's hard to beat. Neurology. 2004 Apr 13;62(7):1036–1037.

Published In

Neurology

DOI

10.1212/wnl.62.7.1036

EISSN

1526-632X

Publication Date

April 13, 2004

Volume

62

Issue

7

Start / End Page

1036 / 1037

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Salicylates
  • Randomized Controlled Trials as Topic
  • Platelet Aggregation Inhibitors
  • Pilot Projects
  • Neurology & Neurosurgery
  • Humans
  • Cerebral Infarction
  • Aspirin